{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:32:31Z","timestamp":1781555551444,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","award":["2022SF-312"],"award-info":[{"award-number":["2022SF-312"]}],"id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200358"],"award-info":[{"award-number":["82200358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2121JQ-412"],"award-info":[{"award-number":["2121JQ-412"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.109957","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T17:36:52Z","timestamp":1678297012000},"page":"109957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["GRK2 participation in cardiac hypertrophy induced by isoproterenol through the regulation of Nrf2 signaling and the promotion of NLRP3 inflammasome and oxidative stress"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1772-0608","authenticated-orcid":false,"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.109957_b0005","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.jacc.2019.03.478","article-title":"ACC\/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison","volume":"73","author":"van der Meer","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2023.109957_b0010","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41569-020-0379-7","article-title":"Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment","volume":"17","author":"Boorsma","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2023.109957_b0015","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacc.2019.11.031","article-title":"Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review","volume":"75","author":"Zelniker","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2023.109957_b0020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jacc.2019.06.053","article-title":"Cardiovascular Aging and Heart Failure","volume":"74","author":"Triposkiadis","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2023.109957_b0025","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10741-011-9278-7","article-title":"Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging","volume":"17","author":"Dhalla","year":"2012","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.intimp.2023.109957_b0030","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41569-019-0220-3","article-title":"G protein-coupled receptor kinases as therapeutic targets in the heart","volume":"16","author":"Pfleger","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2023.109957_b0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/cells10010154","article-title":"GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure","volume":"10","author":"Laudette","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.intimp.2023.109957_b0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14728222.2018.1406925","article-title":"GRK2 as a therapeutic target for heart failure","volume":"22","author":"Cannavo","year":"2018","journal-title":"Expert Opin. Ther. Targets."},{"key":"10.1016\/j.intimp.2023.109957_b0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/138161212799040510","article-title":"GRK2 Inhibition in Heart Failure: Something Old, Something New","volume":"18","author":"Lymperopoulos","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2023.109957_b0050","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.ddstr.2014.01.002","article-title":"G protein-coupled Receptor Kinase 2 as a Therapeutic Target for Heart Failure","volume":"9","author":"Schumacher-Bass","year":"2012","journal-title":"Drug Discov Today Ther. Strateg."},{"key":"10.1016\/j.intimp.2023.109957_b0055","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/01.HYP.0000019130.09167.3B","article-title":"Myocyte redistribution of GRK2 and GRK5 in hypertensive, heart-failure-prone rats","volume":"39","author":"Yi","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.intimp.2023.109957_b0060","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/HYPERTENSIONAHA.110.155960","article-title":"Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression","volume":"56","author":"Sorriento","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.intimp.2023.109957_b0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3390\/ijms19030861","article-title":"The Amino-Terminal Domain of GRK5 Inhibits Cardiac Hypertrophy through the Regulation of Calcium-Calmodulin Dependent Transcription Factors","volume":"19","author":"Sorriento","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109957_b0070","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/ehf2.12706","article-title":"Pharmacological inhibition of GRK2 improves cardiac metabolism and function in experimental heart failure","volume":"7","author":"Ciccarelli","year":"2020","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.intimp.2023.109957_b0075","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/eurheartj\/ehi429","article-title":"Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure","volume":"26","author":"Iaccarino","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.intimp.2023.109957_b0080","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/CIRCHEARTFAILURE.112.966895","article-title":"Targeting the beta-adrenergic receptor system through G-protein-coupled receptor kinase 2: a new paradigm for therapy and prognostic evaluation in heart failure: from bench to bedside","volume":"5","author":"Rengo","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.intimp.2023.109957_b0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yjmcc.2022.07.008","article-title":"GRK2 in cardiovascular disease and its potential as a therapeutic target","volume":"172","author":"Ferrero","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.intimp.2023.109957_b0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2023.109957_b0095","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.7150\/ijbs.33568","article-title":"Role of Pyroptosis in Cardiovascular Diseases and its Therapeutic Implications","volume":"15","author":"Zeng","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2023.109957_b0100","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2023.109957_b0105","doi-asserted-by":"crossref","first-page":"5546867","DOI":"10.1155\/2021\/5546867","article-title":"Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy","volume":"2021","author":"Ma","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2023.109957_b0110","article-title":"NLRP3 Inflammasome: a Novel Insight into Heart Failure","author":"Wang","year":"2022","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.intimp.2023.109957_b0115","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3390\/ijms23031360","article-title":"Heart Failure after Cardiac Surgery: The Role of Halogenated Agents Myocardial Conditioning and Oxidative Stress","volume":"23","author":"Guerrero-Orriach","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109957_b0120","doi-asserted-by":"crossref","first-page":"3090120","DOI":"10.1155\/2021\/3090120","article-title":"Association between Biomarkers of Oxidative Stress and Inflammation with Cardiac Necrosis and Heart Failure in Non-ST Segment Elevation Myocardial Infarction Patients and Various Degrees of Kidney Function","volume":"2021","author":"Roumeliotis","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2023.109957_b0125","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative stress and heart failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.intimp.2023.109957_b0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2021.03.046","article-title":"Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy","volume":"169","author":"Byrne","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2023.109957_b0135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2023.109957_b0140","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/260429","article-title":"The Role of Nrf2-Mediated Pathway in Cardiac Remodeling and Heart Failure","volume":"2014","author":"Zhou","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2023.109957_b0145","doi-asserted-by":"crossref","first-page":"9237263","DOI":"10.1155\/2017\/9237263","article-title":"The Role of Nrf2 in Cardiovascular Function and Disease","author":"Satta","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2023.109957_b0150","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","article-title":"Nrf 2:INrf2 (Keap1) signaling in oxidative stress","volume":"47","author":"Kaspar","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2023.109957_b0155","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/bph.12066","article-title":"Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy","volume":"168","author":"Althurwi","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109957_b0160","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10495-016-1262-1","article-title":"Canstatin inhibits isoproterenol-induced apoptosis through preserving mitochondrial morphology in differentiated H9c2 cardiomyoblasts","volume":"21","author":"Okada","year":"2016","journal-title":"Apoptosis"},{"key":"10.1016\/j.intimp.2023.109957_b0165","doi-asserted-by":"crossref","first-page":"e016364","DOI":"10.1161\/JAHA.120.016364","article-title":"Paroxetine Attenuates Cardiac Hypertrophy Via Blocking GRK2 and ADRB1 Interaction in Hypertension","volume":"10","author":"Sun","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.intimp.2023.109957_b0170","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biopha.2018.09.002","article-title":"Ginsenoside Rb3 protects cardiomyocytes against hypoxia\/reoxygenation injury via activating the antioxidation signaling pathway of PERK\/Nrf2\/HMOX1","volume":"109","author":"Sun","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2023.109957_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173539","article-title":"CaMKIIdelta inhibition protects against myocardial ischemia\/reperfusion injury: Role of Beclin-1-dependent autophagy","volume":"886","author":"Kong","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109957_b0180","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/ars.2007.1474","article-title":"Cardiac hypertrophy: mechanisms and therapeutic opportunities","volume":"9","author":"Gupta","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2023.109957_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108046","article-title":"Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy Fibrosis, and Inflammation","volume":"99","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.109957_b0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40292-013-0001-8","article-title":"G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms","volume":"20","author":"Santulli","year":"2013","journal-title":"High Blood Press Cardiovasc Prev."},{"key":"10.1016\/j.intimp.2023.109957_b0195","unstructured":"Sorriento D, C.M., Santulli G, Illario M, Trimarco B, Iaccarino G., Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization, Transl Med UniSa. 10 (2014) 3-7."},{"key":"10.1016\/j.intimp.2023.109957_b0200","doi-asserted-by":"crossref","unstructured":"Iwata M, Y.T., Baba A, Anzai T, Nakamura I, Wainai Y, Takahashi T, Ogawa S, Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo, Circ Res. 88 (2001) 578-586.","DOI":"10.1161\/01.RES.88.6.578"},{"key":"10.1016\/j.intimp.2023.109957_b0205","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12265-015-9646-0","article-title":"Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy","volume":"8","author":"Sorriento","year":"2015","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.intimp.2023.109957_b0210","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1139\/cjpp-2019-0566","article-title":"Mechanisms for the transition from physiological to pathological cardiac hypertrophy","volume":"98","author":"Oldfield","year":"2020","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109957_b0215","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3390\/antiox10060931","article-title":"Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure","volume":"10","author":"Shah","year":"2021","journal-title":"Antioxidants (Basel)."},{"key":"10.1016\/j.intimp.2023.109957_b0220","doi-asserted-by":"crossref","first-page":"2576310","DOI":"10.1155\/2022\/2576310","article-title":"Effects of Peroxiredoxin 6 and Its Mutants on the Isoproterenol Induced Myocardial Injury in H9C2 Cells and Rats","volume":"2022","author":"Mu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2023.109957_b0225","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2023.109957_b0230","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jacbts.2022.01.010","article-title":"A Cardiac Amino-Terminal GRK2 Peptide Inhibits Maladaptive Adipocyte Hypertrophy and Insulin Resistance During Diet-Induced Obesity","volume":"7","author":"Manaserh","year":"2022","journal-title":"JACC Basic Transl Sci."},{"key":"10.1016\/j.intimp.2023.109957_b0235","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.amjcard.2010.12.006","article-title":"G protein-coupled receptor kinase 2 in patients with acute myocardial infarction","volume":"107","author":"Santulli","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.intimp.2023.109957_b0240","doi-asserted-by":"crossref","unstructured":"Zhang J, H.L., Shi X, Yang L, Hua F, Ma J, Zhu W, Liu X, Xuan R, Shen Y, Liu J, Lai X, Yu P, Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK\/NLRP3 inflammasome pathway, Aging (Albany NY). 12 (2020) 24270-24287.","DOI":"10.18632\/aging.202143"},{"key":"10.1016\/j.intimp.2023.109957_b0245","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/med.21781","article-title":"NLRP3 inflammasome in cardiovascular diseases: Pathophysiological and pharmacological implications","volume":"41","author":"Pellegrini","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.intimp.2023.109957_b0250","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00395-017-0663-9","article-title":"Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases","volume":"113","author":"Liu","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.intimp.2023.109957_b0255","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fphar.2019.00112","article-title":"G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases","volume":"10","author":"Murga","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109957_b0260","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.114.300513","article-title":"G protein-coupled receptor kinase 2: a link between myocardial contractile function and cardiac metabolism","volume":"114","author":"Woodall","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2023.109957_b0265","doi-asserted-by":"crossref","first-page":"e0182110","DOI":"10.1371\/journal.pone.0182110","article-title":"G protein-coupled receptor kinase 2 promotes cardiac hypertrophy","volume":"12","author":"Schlegel","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.109957_b0270","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.3390\/ijms23052777","article-title":"Myocardial GRK2 Reduces Fatty Acid Metabolism and beta-Adrenergic Receptor-Mediated Mitochondrial Responses","volume":"23","author":"Zhai","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109957_b0275","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1161\/HYPERTENSIONAHA.120.15130","article-title":"Role of Endothelial G Protein-Coupled Receptor Kinase 2 in Angioedema","volume":"76","author":"Gambardella","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.intimp.2023.109957_b0280","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional Regulation by Nrf2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxid. Redox Signal."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:56:56Z","timestamp":1761587816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923002771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":56,"alternative-id":["S1567576923002771"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109957","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GRK2 participation in cardiac hypertrophy induced by isoproterenol through the regulation of Nrf2 signaling and the promotion of NLRP3 inflammasome and oxidative stress","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109957"}}